Literature DB >> 21274124

Medical problems related to air travel.

G Y Takahashi.   

Abstract

Air travel has become the preferred method of transportation for many Canadians, some of whom would otherwise be unable to travel long distances. Airline medical departments will provide advice and assistance with prior notification. The pressurized cabin has a slightly hypoxic atmosphere, so cardiac and chronic pulmonary patients require individual evaluations before departure. Severely anemic patients and those with neurological disorders may need to take special precautions, as will those with conditions affected by pressure changes. Aside from a few contraindications, the majority of patients can enjoy the benefits of commercial air travel, with proper guidance from their family physician.

Entities:  

Year:  1985        PMID: 21274124      PMCID: PMC2327725     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  The carriage of invalid passengers by air.

Authors:  R L Green
Journal:  Br J Hosp Med       Date:  1977-01

2.  Air travel and patients with chronic obstructive pulmonary disease.

Authors:  H Gong
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

3.  Air travel for the chronically ill and the elderly.

Authors:  M W Voss
Journal:  Am Fam Physician       Date:  1983-03       Impact factor: 3.292

4.  Fitness to travel by air. I: Physiological considerations.

Authors:  F J Mills; R M Harding
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16

5.  Studies of self-mutilating patients.

Authors:  M A Simpson
Journal:  Am J Psychiatry       Date:  1981-06       Impact factor: 18.112

6.  The morbidity of sickle cell trait: a review of the literature.

Authors:  D A Sears
Journal:  Am J Med       Date:  1978-06       Impact factor: 4.965

7.  Air travel hypoxemia with chronic obstructive pulmonary disease.

Authors:  J S Schwartz; H Z Bencowitz; K M Moser
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.